Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root.

OBJECTIVE: Stentless valves convey important hemodynamic benefits but are used selectively depending on aortic root structure. The Freestyle valve (Medtronic, Inc, Minneapolis, Minn) is a versatile device that can be implanted by different methods depending on operating conditions. We aimed to demon...

Full description

Bibliographic Details
Main Authors: Westaby, S, Jin, X, Katsumata, T, Arifi, A, Braidley, P
Format: Journal article
Language:English
Published: 1998
_version_ 1826304699464155136
author Westaby, S
Jin, X
Katsumata, T
Arifi, A
Braidley, P
author_facet Westaby, S
Jin, X
Katsumata, T
Arifi, A
Braidley, P
author_sort Westaby, S
collection OXFORD
description OBJECTIVE: Stentless valves convey important hemodynamic benefits but are used selectively depending on aortic root structure. The Freestyle valve (Medtronic, Inc, Minneapolis, Minn) is a versatile device that can be implanted by different methods depending on operating conditions. We aimed to demonstrate that a stentless valve could be used in every patient without increased risk of morbidity or mortality. We documented the effects of this valve on clinical outcome and left ventricular mechanics. METHODS: The Freestyle valve was implanted by the modified subcoronary method into 200 consecutive unselected patients who received a tissue valve in the aortic position and by root replacement in 2. Forty-three percent were older than 75 years. Forty percent underwent coronary bypass. Detailed clinical and echocardiographic follow-up (Food and Drug Administration protocol) was used out to 3 years. RESULTS: Mean ischemic time was 43+/-6 minutes for isolated aortic valve replacement and 63+/-14 minutes with concomitant procedures. Thirty-day mortality was 6%, none of the deaths being valve related. Hemodynamic function improved progressively with falling valve gradients and increased effective orifice areas. Left ventricular mass fell within normal limits over 2 years, but at 3 years there was a non-valve-related upswing. No instances of valve thrombosis, hemolysis, or paravalvular leak were noted. Less than 5% had mild to moderate aortic regurgitation. CONCLUSIONS: The Freestyle valve can be used in virtually every patient with aortic valve disease and provides superlative hemodynamic outcome. Hospital mortality and morbidity are similar to those reported for stented valves in an elderly population.
first_indexed 2024-03-07T06:21:46Z
format Journal article
id oxford-uuid:f2f347ad-9033-4480-a96f-6e6cc617e964
institution University of Oxford
language English
last_indexed 2024-03-07T06:21:46Z
publishDate 1998
record_format dspace
spelling oxford-uuid:f2f347ad-9033-4480-a96f-6e6cc617e9642022-03-27T12:08:01ZValve replacement with a stentless bioprosthesis: versatility of the porcine aortic root.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f2f347ad-9033-4480-a96f-6e6cc617e964EnglishSymplectic Elements at Oxford1998Westaby, SJin, XKatsumata, TArifi, ABraidley, POBJECTIVE: Stentless valves convey important hemodynamic benefits but are used selectively depending on aortic root structure. The Freestyle valve (Medtronic, Inc, Minneapolis, Minn) is a versatile device that can be implanted by different methods depending on operating conditions. We aimed to demonstrate that a stentless valve could be used in every patient without increased risk of morbidity or mortality. We documented the effects of this valve on clinical outcome and left ventricular mechanics. METHODS: The Freestyle valve was implanted by the modified subcoronary method into 200 consecutive unselected patients who received a tissue valve in the aortic position and by root replacement in 2. Forty-three percent were older than 75 years. Forty percent underwent coronary bypass. Detailed clinical and echocardiographic follow-up (Food and Drug Administration protocol) was used out to 3 years. RESULTS: Mean ischemic time was 43+/-6 minutes for isolated aortic valve replacement and 63+/-14 minutes with concomitant procedures. Thirty-day mortality was 6%, none of the deaths being valve related. Hemodynamic function improved progressively with falling valve gradients and increased effective orifice areas. Left ventricular mass fell within normal limits over 2 years, but at 3 years there was a non-valve-related upswing. No instances of valve thrombosis, hemolysis, or paravalvular leak were noted. Less than 5% had mild to moderate aortic regurgitation. CONCLUSIONS: The Freestyle valve can be used in virtually every patient with aortic valve disease and provides superlative hemodynamic outcome. Hospital mortality and morbidity are similar to those reported for stented valves in an elderly population.
spellingShingle Westaby, S
Jin, X
Katsumata, T
Arifi, A
Braidley, P
Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root.
title Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root.
title_full Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root.
title_fullStr Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root.
title_full_unstemmed Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root.
title_short Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root.
title_sort valve replacement with a stentless bioprosthesis versatility of the porcine aortic root
work_keys_str_mv AT westabys valvereplacementwithastentlessbioprosthesisversatilityoftheporcineaorticroot
AT jinx valvereplacementwithastentlessbioprosthesisversatilityoftheporcineaorticroot
AT katsumatat valvereplacementwithastentlessbioprosthesisversatilityoftheporcineaorticroot
AT arifia valvereplacementwithastentlessbioprosthesisversatilityoftheporcineaorticroot
AT braidleyp valvereplacementwithastentlessbioprosthesisversatilityoftheporcineaorticroot